Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kuifei Chen"'
Autor:
Liqiao Hou, Kuifei Chen, Chao Zhou, Xingni Tang, Changhui Yu, Haijian Jia, Qianyi Xu, Suna Zhou, Haihua Yang
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 48, Iss , Pp 100828- (2024)
Purpose: To establish a radiomics model using radiomics features from different region of interests (ROI) based on dosimetry-related regions in enhanced computed tomography (CT) simulated images to predict radiation pneumonitis (RP) in patients with
Externí odkaz:
https://doaj.org/article/3256583e96cd4bc9bc4edb584835da54
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background CCRT is presently the standard treatment for LA-NSCLC. RP is one of the main obstacles to the completion of thoracic radiation therapy, resulting in limited survival benefits in NSCLC patients. This research aims to explore the ro
Externí odkaz:
https://doaj.org/article/7b4ebcf357f6402fbde6cb3e51fdd981
Autor:
Xiate Zhou, Jian Zhu, Chao Zhou, Wei Wang, Weijun Ding, Meng Chen, Kuifei Chen, Shuling Li, Xiaofeng Chen, Haihua Yang
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Previous researches have demonstrated that adaptive replanning during intensity-modulated radiation therapy (IMRT) could enhance the prognosis of patients with nasopharyngeal carcinoma (NPC). However, the delineation of replanning
Externí odkaz:
https://doaj.org/article/c169007efa5744e8bdf243ac9101cb93
Autor:
Shuling Li, Kuifei Chen, Meiwen Yang, Swe Swe Hlaing, Meng Chen, Pinjun Gu, Yinnan Meng, Haihua Yang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionRadiotherapy may augment systemic antitumor responses to immunotherapy. We did a retrospective study to infer whether radiotherapy improves outcomes to immunotherapy in patients with stage III and IV non-small-cell lung cancer (NSCLC).Met
Externí odkaz:
https://doaj.org/article/faeb079a6f4f4b1f840aa6dee5add9cd
Publikováno v:
Life, Vol 13, Iss 4, p 884 (2023)
Purpose: to develop a radiogenomic model on the basis of 18F-FDG PET/CT radiomics and clinical-parameter EGFR for predicting PFS stratification in lung-cancer patients after SBRT treatment. Methods: A total of 123 patients with lung cancer who had un
Externí odkaz:
https://doaj.org/article/81e22718d2194cab85a0a04e6352699c
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundEpidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective in advanced EGFR-mutation non-small cell lung cancer (NSCLC) but the magnitude of tumor regression varies, and drug resistance is unavoidable. The pleckst
Externí odkaz:
https://doaj.org/article/958609edff264cdc9333edc008bdd95f
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
IDO1-mediated immune escape can lead to the malignant progression of tumors. However, the precise mechanism of IDO1 remains unclear. This study showed that IDO1 can bind to GBP1 and increase the extracellular secretion of IDO1 with the assistance of
Externí odkaz:
https://doaj.org/article/9e50e2bcccb0451abac16001865cc086
Publikováno v:
J Thorac Dis
BACKGROUND: Clinically, there is a lack of simple and feasible indicators to predict the efficacy of stereotactic body radiation therapy (SBRT). Circulating lymphocyte counts (CLCs) is considered to be related to curative effect in conventional radio
Autor:
Xiate Zhou, Wei Wang, Chao Zhou, Jian Zhu, Weijun Ding, Meng Chen, Kuifei Chen, Yangyang Shi, Xiaofeng Chen, Feng-Ming Kong, Haihua Yang
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 170
Recent studies show that adaptive replanning for patients with nasopharyngeal carcinoma (NPC) during intensity-modulated radiation therapy (IMRT) improve the short-term local-regional recurrence-free survival (LRFS), and quality of life (QoL). We aim